Pharmacopoeial Quality Requirements for Compounded Pharmaceuticals: Present and Future


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Issues related to regulation of the quality of compounded medicinal preparations by the State Pharmacopoeia of the Russian Federation are considered. Topical questions of the development and implementation of both general clauses and particular monographs related to compounded pharmaceuticals in national pharmacopoeial science and practice are discussed.

Sobre autores

L. Shishova

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation

Email: chem@folium.ru
Rússia, 8/2 Petrovskii Blvd., Moscow, 127051

E. Sakanyan

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation

Email: chem@folium.ru
Rússia, 8/2 Petrovskii Blvd., Moscow, 127051

T. Shemeryankina

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation

Email: chem@folium.ru
Rússia, 8/2 Petrovskii Blvd., Moscow, 127051

O. Gubareva

Scientific Center for Expert Evaluation of Medicinal Products, Ministry of Health of the Russian Federation

Email: chem@folium.ru
Rússia, 8/2 Petrovskii Blvd., Moscow, 127051

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2017